Rockwell Medical (NASDAQ:RMTI) jumped over 7 percent today after the  manufacturer of hemodialysis concentrate solutions and dialysis kits had coverage initiated by FBR Capital Markets .  FBR announced that it initiated coverage of RMTI with an underperfom rating and a dismal price target of $6.00.  Naturally, investors laughed at the rating from such a small,